Therapeutic Education Using an Internet Application in Hereditary

Updated 05/31/2024

Status Completed

Clinical Trial Summary

The main purpose is to evaluate the feasibility (global use) of a therapeutic patient education program using a specific web application in patients with hereditary ichthyosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03641261
Study type	Interventional
Source	University Hospital, Toulouse
Contact
Status	Completed
Phase	N/A
Start date	October 29, 2018
Completion date	February 21, 2023

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03051347` - Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments	N/A
	Completed	`NCT00004690` - Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis	Phase 3
	Completed	`NCT00074685` - National Registry for Ichthyosis and Related Disorders
	Completed	`NCT03796052` - Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients	N/A
	Recruiting	`NCT05954416` - FARD (RaDiCo Cohort) (RaDiCo-FARD)
	Active, not recruiting	`NCT05295732` - The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis	Phase 3
	Terminated	`NCT02655861` - A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
	Recruiting	`NCT03464994` - Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO)	N/A
	Recruiting	`NCT03417856` - Defining the Skin and Blood Biomarkers of Ichthyosis
	Terminated	`NCT04697056` - A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis	Phase 2
	Recruiting	`NCT06330350` - Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
	Enrolling by invitation	`NCT06330324` - Reproductive Options in Inherited Skin Diseases
	Completed	`NCT03041038` - The Efficacy and Safety of Secukinumab in Patients With Ichthyoses	Phase 2
	Not yet recruiting	`NCT06362447` - Efficacy of Injectable Gentamicin in Hereditary Ichthyosis	Phase 2
	Active, not recruiting	`NCT04549792` - An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses	Early Phase 1